About Bora Pharmaceuticals
Bora Pharmaceuticals is a company based in Taipei (Taiwan) founded in 2008. Bora Pharmaceuticals has completed 2 acquisitions, including Pyros Pharma and Upsher-Smith. Bora Pharmaceuticals operates in a competitive market with competitors including Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bora Pharmaceuticals Co Ltd
-
Annual Revenue
$19.25 B35.53as on Dec 31, 2024
-
Net Profit
$3.94 B29.99as on Dec 31, 2024
-
EBITDA
$4.41 B-24.71as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Pyros Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bora Pharmaceuticals
Bora Pharmaceuticals is a publicly listed company on the TWSE with ticker symbol 6472 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Bora Pharmaceuticals
Detailed funding history for Bora Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bora Pharmaceuticals
Bora Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Pyros Pharma and Upsher-Smith.
Investment portfolio details for Bora Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing treatments for rare diseases, with a pipeline of innovative products aimed at improving patient outcomes.
|
Locked | Locked | 2017 | Locked | |
|
Manufacturer of generic drugs
|
Locked | Locked | 1919 | Locked |
Complete acquisition details for Bora Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bora Pharmaceuticals
Detailed financials for Bora Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bora Pharmaceuticals Comparisons
Peer comparison for Bora Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bora Pharmaceuticals
Bora Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| Locked | Locked | Locked |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Detailed competitors of Bora Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bora Pharmaceuticals
Complete news archive for Bora Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bora Pharmaceuticals
Bora Pharmaceuticals was founded in 2008.
Bora Pharmaceuticals is headquartered in Taipei, Taiwan.
Bora Pharmaceuticals was established in 2008 in Taipei, Taiwan, within the pharmaceutical sector. Research, development, manufacturing, and distribution of western medicines and health care products are handled by the company. Key offerings include Lexapro for antidepressants, Lendormin for hypnosis, Deanxit for anxiety and depression treatment, and Ebixa for Alzheimers disease management, among others. These products are primarily supplied to domestic markets in Taiwan.
Bora Pharmaceuticals's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Yes, Bora Pharmaceuticals is publicly traded on TWSE under the ticker symbol 6472.
Bora Pharmaceuticals has made 2 acquisitions, including Pyros Pharma, and Upsher-Smith.
The ticker symbol of Bora Pharmaceuticals is 6472 on TWSE.